Food allergy oral immunotherapy

Area of Science:

• Allergy and Immunology
• Clinical Therapeutics
• Food Science

Background:

• Food allergy oral immunotherapy (OIT) effectively induces desensitization in most patients.
• Sustained unresponsiveness after OIT cessation is achieved in a subset of individuals.
• Adverse events range from mild symptoms to anaphylaxis, necessitating careful risk-benefit assessment.

Purpose of the Study:

• To review the efficacy and safety of OIT for food allergies.
• To discuss the limitations of current OIT approaches and the need for next-generation therapies.
• To emphasize the importance of shared decision-making in OIT candidate selection.

Main Methods:

• Review of existing literature on single-allergen and multi-allergen OIT.
• Analysis of safety and efficacy outcomes reported in OIT studies.
• Discussion of emerging therapeutic strategies and future research directions.

Main Results:

• OIT demonstrates clinically relevant immunomodulation and desensitization.
• Multi-allergen OIT shows favorable safety and efficacy.
• First-generation OIT treatments have limitations requiring further development.

Conclusions:

• Next-generation OIT therapies are needed to improve efficacy, minimize risk, and broaden applicability.
• Combination therapies with biologics or adjuvants may enhance outcomes.
• Shared decision-making is essential for optimal OIT candidate selection and management.